20Jan 2024
L-6 and HNL Levels Predict Stroke-Associated Pneumonia Risk in AIS Patients

L-6 and HNL Levels Predict Stroke-Associated Pneumonia Risk in AIS Patients

A study investigates the predictive value of interleukin-6 (IL-6) and human neutrophil lipocalin (HNL) in stroke-associated pneumonia (SAP) among acute ischemic stroke (AIS) patients. Analyzing data from 108 patients, logistic regression identified dysphagia, increased NIHSS scores, elevated IL-6, and HNL as independent SAP risk factors. ROC curve analysis revealed IL-6 (AUC: 0.881) and HNL (AUC: 0.896) efficacy, with combined detection enhancing predictive accuracy (AUC: 0.952). IL-6 ≥ 6.89 pg/mL and HNL ≥ 99.66 ng/mL signify SAP risk, aiding high-risk patient identification.

  • #general medicine

Like

Save

Share